These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 30739228)

  • 21. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
    Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
    Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biomarkers of neutrophilic inflammation in exhaled air of cystic fibrosis children with bacterial airway infections.
    Bodini A; D'Orazio C; Peroni D; Corradi M; Folesani G; Baraldi E; Assael BM; Boner A; Piacentini GL
    Pediatr Pulmonol; 2005 Dec; 40(6):494-9. PubMed ID: 16229003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pseudomonas aeruginosa and Periodontal Pathogens in the Oral Cavity and Lungs of Cystic Fibrosis Patients: a Case-Control Study.
    Rivas Caldas R; Le Gall F; Revert K; Rault G; Virmaux M; Gouriou S; Héry-Arnaud G; Barbier G; Boisramé S
    J Clin Microbiol; 2015 Jun; 53(6):1898-907. PubMed ID: 25854483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pseudomonas-infected cystic fibrosis patient sputum inhibits the bactericidal activity of normal human serum.
    Schiller NL; Millard RL
    Pediatr Res; 1983 Sep; 17(9):747-52. PubMed ID: 6413945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis.
    Valenza G; Tappe D; Turnwald D; Frosch M; König C; Hebestreit H; Abele-Horn M
    J Cyst Fibros; 2008 Mar; 7(2):123-7. PubMed ID: 17693140
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Refining the Application of Microbial Lipids as Tracers of Staphylococcus aureus Growth Rates in Cystic Fibrosis Sputum.
    Neubauer C; Kasi AS; Grahl N; Sessions AL; Kopf SH; Kato R; Hogan DA; Newman DK
    J Bacteriol; 2018 Dec; 200(24):. PubMed ID: 30249710
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patients.
    Sajjan US; Tran LT; Sole N; Rovaldi C; Akiyama A; Friden PM; Forstner JF; Rothstein DM
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3437-44. PubMed ID: 11709321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular typing of the bacterial flora in sputum of cystic fibrosis patients.
    Kolak M; Karpati F; Monstein HJ; Jonasson J
    Int J Med Microbiol; 2003 Aug; 293(4):309-17. PubMed ID: 14503795
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cystic fibrosis and bacterial colonization define the sputum N-glycosylation phenotype.
    Venkatakrishnan V; Thaysen-Andersen M; Chen SC; Nevalainen H; Packer NH
    Glycobiology; 2015 Jan; 25(1):88-100. PubMed ID: 25190359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility of microorganisms isolated from sputum culture of patients with cystic fibrosis: Methicillin-resistant Staphylococcus aureus as a serious concern.
    Mazloomi Nobandegani N; Mahmoudi S; Pourakbari B; Hosseinpour Sadeghi R; Najafi Sani M; Farahmand F; Motamed F; Nabavizadeh Rafsanjani R; Mamishi S
    Microb Pathog; 2016 Nov; 100():201-204. PubMed ID: 27666507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neutrophil elastase correlates with increased sphingolipid content in cystic fibrosis sputum.
    Karandashova S; Kummarapurugu A; Zheng S; Kang L; Sun S; Rubin BK; Voynow JA
    Pediatr Pulmonol; 2018 Jul; 53(7):872-880. PubMed ID: 29624923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of fungal growth by Pseudomonas aeruginosa and Pseudomonas cepacia isolated from patients with cystic fibrosis.
    Kerr J
    J Infect; 1994 May; 28(3):305-10. PubMed ID: 7522262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis.
    Tunney MM; Field TR; Moriarty TF; Patrick S; Doering G; Muhlebach MS; Wolfgang MC; Boucher R; Gilpin DF; McDowell A; Elborn JS
    Am J Respir Crit Care Med; 2008 May; 177(9):995-1001. PubMed ID: 18263800
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Colonization of CF patients' upper airways with S. aureus contributes more decisively to upper airway inflammation than P. aeruginosa.
    Janhsen WK; Arnold C; Hentschel J; Lehmann T; Pfister W; Baier M; Böer K; Hünniger K; Kurzai O; Hipler UC; Mainz JG
    Med Microbiol Immunol; 2016 Oct; 205(5):485-500. PubMed ID: 27377929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of viable but non-culturable Pseudomonas aeruginosa in cystic fibrosis by qPCR: a validation study.
    Mangiaterra G; Amiri M; Di Cesare A; Pasquaroli S; Manso E; Cirilli N; Citterio B; Vignaroli C; Biavasco F
    BMC Infect Dis; 2018 Dec; 18(1):701. PubMed ID: 30587160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term coexistence of
    Monteiro R; Magalhães AP; Pereira MO; Sousa AM
    Future Microbiol; 2021 Aug; 16():879-893. PubMed ID: 34319132
    [No Abstract]   [Full Text] [Related]  

  • 37. Incidence and risk of cross-colonization in cystic fibrosis holiday camps.
    Hoogkamp-Korstanje JA; van der Laag J
    Antonie Van Leeuwenhoek; 1980; 46(1):100-1. PubMed ID: 6772098
    [No Abstract]   [Full Text] [Related]  

  • 38. Adult cystic fibrosis: association of acute pulmonary exacerbations and increasing severity of lung disease with auxotrophic mutants of Pseudomonas aeruginosa.
    Taylor RF; Hodson ME; Pitt TL
    Thorax; 1993 Oct; 48(10):1002-5. PubMed ID: 8256228
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotyping of Pseudomonas aeruginosa sputum and stool isolates from cystic fibrosis patients: evidence for intestinal colonization and spreading into toilets.
    Döring G; Bareth H; Gairing A; Wolz C; Botzenhart K
    Epidemiol Infect; 1989 Dec; 103(3):555-64. PubMed ID: 2514111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staphylococcus aureus Impacts Pseudomonas aeruginosa Chronic Respiratory Disease in Murine Models.
    Cigana C; Bianconi I; Baldan R; De Simone M; Riva C; Sipione B; Rossi G; Cirillo DM; Bragonzi A
    J Infect Dis; 2018 Mar; 217(6):933-942. PubMed ID: 29216403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.